European Patent Office Supports Validity of Pfizer's Lipitor® Patent

« Wyeth: One of the U.S. EPA's Best Workplaces for Commuters | Main | Strattera®, Effective in Treating ADHD Symptoms in Children and Adolescents with ADHD and Reading Disorders, New Study Says »

Oct29

Gloria Gamat

October 29, 2006

Know More: Lawsuits and Litigations, Patents and Clinical Trials

As if Ranbaxy (BOM: 500359) needed more salt to add to its Lipitor patent wound...

Once more another patent office, this time the European Patent Office (EPO) has issued an upholding opinion to Pfizer’s calcium salt patent covering Lipitor®, in its entirety.

The upholding opinion was provided by the EPO at the request of a Spanish court that is hearing a patent infringement case filed against Pfizer (NYSE: PFE) by generic manufacturer Ranbaxy.

The EPO rejected arguments by Ranbaxy that a patent covering atorvastatin calcium, the active ingredient in Lipitor, is invalid for "lack of novelty" and "lack of inventive step."

In Spain, the famous cholesterol drug –Lipitor®- is sold under the brand names Zarator and Cardyl.

Source: Pfizer, Inc.

related entries

0 Comments/Trackbacks

submit a trackback

TrackBack URL for this entry:

Comment Preview

« Wyeth: One of the U.S. EPA's Best Workplaces for Commuters | Main | Strattera®, Effective in Treating ADHD Symptoms in Children and Adolescents with ADHD and Reading Disorders, New Study Says »

Advertise

Watch the Digital Health Revolution

Related Resources

Advertise Here

Current News

Press Releases

resources

Bookmark this Page
Write for us
About us
Team
Contact
Subscribe
Advertise
Network Map
Privacy
Disclaimer

Support This Blog

Know More Media - Health Care / Pharmaceutical / Fitness

know more media network

View Network Map

Network Feed List (OPML)

Know More Media Network
Feed

we support unitus

PRWeb

Influencer

PharmaGazette is a member of the Know More Media network of business related blogs.

Here are some current headlines from some of our business publications:

ProductivityGoal

CallCenterScript

AdHurl

TheBizofKnowledge

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 619

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 620

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 621

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 622

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 737

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 738

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 739

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 740

Pharmaceutical Industry discussion, review, analysis, news and information.

related entries

0 Comments/Trackbacks

submit a trackback

post a comment

Comment Preview

Advertise

Related Resources

recent comments

sponsored ads

topics

subscribe